Professor Andrew Lo on the Cancer Mega-Fund – Will Financial Engineering Cure Cancer?
This Financial Sense Newshour program is available only as a premium, paid "FS Insider" release.
For advance notice of release of premium, paid "FS Insider" content or to purchase a monthly or annual subscription to "FS Insider" content, go to www.financialsense.com/subscribe.
Jim welcomes back Dr. Andrew Lo, Professor of Finance at the MIT Sloan School of Management and the director of MIT's Laboratory for Financial Engineering. They discuss Professor Lo’s proposal to use financial engineering to spread risks among investors and provide financial incentives to develop successful cancer treatments. Professor Lo notes that pharmaceutical companies feel challenged because there isn’t enough funding at the early stages of clinical research, and the pipeline is becoming thinner and thinner because there’s less and less venture capital money going into the industry. He explains how the Cancer Mega-Fund works, and how investors can make good money in finding a cure for cancer. In 2012 Time Magazine named Andrew Lo to its list of the 100 most influential people in the world.
About James J Puplava CFP
|06/19/2018||Everything You Want to Know About 529 Plans and Saving for College||bcast|
|06/18/2018||Social Security: Now or Later||bcast|
|06/16/2018||Central Banks to Markets: We’re Removing Liquidity||bcast|
|06/16/2018||Rising Dollar Impacting International Markets, Focus on US, Says Ari Wald||bcast|
|06/12/2018||Money and Your Family – The Importance of Communication||bcast|
|06/11/2018||Leaving a Legacy||bcast|
|06/09/2018||The Case for and Against Higher Oil Prices||bcast|
|06/09/2018||Market Update with Art Hill; Keith Barron: Peak Gold Is Here||bcast|
|06/05/2018||How to Remain Healthy for the Rest of Your Life||bcast|
|06/04/2018||How to Enjoy a Tax-Free Environment, Legally||bcast|